These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7751415)

  • 21. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy.
    Kuriyama S; Otsuka Y; Iida R; Matsumoto K; Tokudome G; Hosoya T
    Intern Med; 2005 Dec; 44(12):1239-46. PubMed ID: 16415543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension in diabetes mellitus.
    Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
    Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
    [No Abstract]   [Full Text] [Related]  

  • 23. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension in diabetic patients. An overview of interventional studies to preserve renal function.
    Bakris GL
    Am J Hypertens; 1993 Apr; 6(4):140S-147S. PubMed ID: 8507441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive treatment of patients with diabetes and hypertension.
    Julius S; Majahalme S; Palatini P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):310S-316S. PubMed ID: 11721889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choice of antihypertensive drug in the diabetic patient.
    Ong HT; Cheah JS
    MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trandolapril/verapamil combination in hypertensive diabetic patients.
    García Donaire JA; Ruilope LM
    Vasc Health Risk Manag; 2007; 3(1):77-82. PubMed ID: 17583177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension treatment in patients with diabetes].
    Duława J
    Przegl Lek; 1997; 54(11):777-80. PubMed ID: 9501688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Management of Hypertensive Subjects without and with Diabetes Mellitus Type II.
    Safar ME; Blacher J; Protogerou AD
    Med Clin North Am; 2017 Jan; 101(1):159-167. PubMed ID: 27884226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic challenges in the obese diabetic patient with hypertension.
    Bakris GL; Weir MR; Sowers JR
    Am J Med; 1996 Sep; 101(3A):33S-46S. PubMed ID: 8876473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
    Jeffers BW; Robbins J; Bhambri R; Wajsbrot D
    Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and diabetes: new therapeutic options.
    Deedwania PC
    Arch Intern Med; 2000 Jun; 160(11):1585-94. PubMed ID: 10847251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of isolated systolic hypertension in diabetes mellitus type 2.
    Os I; Gudmundsdottir H; Kjeldsen SE; Oparil S
    Diabetes Obes Metab; 2006 Jul; 8(4):381-7. PubMed ID: 16776744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure reduction as a preventive treatment of diabetic nephropathy.
    Ribstein J; Mimran A
    Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypertension and diabetes - dangerous syntropy].
    Rett K
    MMW Fortschr Med; 2017 Oct; 159(18):42-45. PubMed ID: 29071615
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes.
    Peverill RE
    Med J Aust; 2002 Mar; 176(6):296-7; author reply 297. PubMed ID: 11999268
    [No Abstract]   [Full Text] [Related]  

  • 39. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.